| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 1639-1647, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
EP Henske, LL Wessner, J Golden, BW Scheithauer, AO Vortmeyer, Z Zhuang, AJ Klein-Szanto, DJ Kwiatkowski and RS Yeung
Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA. henske@tuberous.fccc.edu
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by seizures, mental retardation, and tumors of skin, brain, heart, and kidney. In this study, we focused on two of the most frequent tumors in TSC patients, renal angiomyolipomas and subependymal giant cell astrocytomas (SEGAs). Two questions were addressed. First, is loss of tuberin, the product of the TSC2 gene, seen in both renal and central nervous system tumors from TSC patients? Second, when loss of tuberin occurs, does it affect each of the cell types seen in these tumors? We used a loss of heterozygosity approach to identify tumors from TSC2 patients. We found loss of tuberin immunostaining in the spindle and epithelioid cells but not in the giant cells of six TSC2 SEGAs. We also found loss of tuberin immunostaining in all three cell types (smooth muscle, fat, and vessels) of six TSC2 angiomyolipomas. Chromosome 16p13 loss of heterozygosity occurred in both spindle and epithelioid cells of a SEGA and in smooth muscle and fat but not the vessels of two angiomyolipomas. These results support a two-hit tumor suppressor model for the pathogenesis of SEGAs and angiomyolipomas. The vascular elements of angiomyolipomas and the giant cells of SEGAs may be reactive rather than neoplastic.
This article has been cited by other articles:
 |
|
 |
|
  S. Li, F. Takeuchi, J.-a. Wang, Q. Fan, T. Komurasaki, E. M. Billings, G. Pacheco-Rodriguez, J. Moss, and T. N. Darling Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas PNAS, March 4, 2008; 105(9): 3539 - 3544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D'Armiento, K. Imai, J. Schiltz, N. Kolesnekova, D. Sternberg, K. Benson, A. Pardo, M. Selman, T. Smolarek, M. Vundavalli, et al. Identification of the Benign Mesenchymal Tumor Gene HMGA2 in Lymphangiomyomatosis Cancer Res., March 1, 2007; 67(5): 1902 - 1909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Lesma, V. Grande, S. Carelli, D. Brancaccio, M. P. Canevini, R. M. Alfano, G. Coggi, A. M. Di Giulio, and A. Gorio Isolation and Growth of Smooth Muscle-Like Cells Derived from Tuberous Sclerosis Complex-2 Human Renal Angiomyolipoma: Epidermal Growth Factor Is the Required Growth Factor Am. J. Pathol., October 1, 2005; 167(4): 1093 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Govindarajan, D. J. Brat, M. Csete, W. D. Martin, E. Murad, K. Litani, C. Cohen, F. Cerimele, M. Nunnelley, B. Lefkove, et al. Transgenic Expression of Dominant Negative Tuberin through a Strong Constitutive Promoter Results in a Tissue-specific Tuberous Sclerosis Phenotype in the Skin and Brain J. Biol. Chem., February 18, 2005; 280(7): 5870 - 5874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Astrinidis and E. Petri Henske Aberrant Cellular Differentiation and Migration in Renal and Pulmonary Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 710 - 715. [Abstract] [PDF]
|
|
|
|
|
|
P. B. Crino Molecular Pathogenesis of Tuber Formation in Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 716 - 725. [Abstract] [PDF]
|
|
|
|
|
|
S. Jozwiak, D. Kwiatkowski, K. Kotulska, M. Larysz-Brysz, J. Lewin-Kowalik, W. Grajkowska, and M. Roszkowski Tuberin and Hamartin Expression Is Reduced in the Majority of Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex Consistent With a Two-Hit Model of Pathogenesis J Child Neurol, February 1, 2004; 19(2): 102 - 106. [Abstract] [PDF]
|
|
|
|
|
|
M. Karbowniczek, J. Yu, and E. P. Henske Renal Angiomyolipomas from Patients with Sporadic Lymphangiomyomatosis Contain Both Neoplastic and Non-Neoplastic Vascular Structures Am. J. Pathol., February 1, 2003; 162(2): 491 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Hodges, S. Li, J. Maynard, L. Parry, R. Braverman, J. P. Cheadle, J. E. DeClue, and J. R. Sampson Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin Hum. Mol. Genet., December 1, 2001; 10(25): 2899 - 2905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Schon, T. Ruzicka, R. Wienecke, I. Fackler, and P. Lehmann Multiple Eruptive Angiofibromas of the Trunk: Case Report of a New Entity? Arch Dermatol, November 1, 2001; 137(11): 1533 - 1535. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Arbiser, R. Yeung, S. W. Weiss, Z. K. Arbiser, M. B. Amin, C. Cohen, D. Frank, S. Mahajan, G. S. Herron, J. Yang, et al. The Generation and Characterization of a Cell Line Derived from a Sporadic Renal Angiomyolipoma : Use of Telomerase to Obtain Stable Populations of Cells from Benign Neoplasms Am. J. Pathol., August 1, 2001; 159(2): 483 - 491. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. B. Crino and E. P. Henske New developments in the neurobiology of the tuberous sclerosis complex Neurology, October 22, 1999; 53(7): 1384 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kwiatkowska, J. Wigowska-Sowinska, D. Napierala, R. Slomski, and D. J. Kwiatkowski Mosaicism in Tuberous Sclerosis as a Potential Cause of the Failure of Molecular Diagnosis N. Engl. J. Med., March 4, 1999; 340(9): 703 - 707. [Full Text] [PDF]
|
|
|
|
|
|
G. Rennebeck, E. V. Kleymenova, R. Anderson, R. S. Yeung, K. Artzt, and C. L. Walker Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development PNAS, December 22, 1998; 95(26): 15629 - 15634. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
